It is a pharma private limited company based in Uppal, Telangana, India, established in 1999.
1999 | Uppal, Telangana, India | ActiveSuzikem Drugs Private Limited, a active private limited company, was established on 30 June 1999 in Uppal, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24110TG1999PTC031995. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.80 M and a paid-up capital of ₹4.61 M.
It upholds a compliant status. Employing 9 professional, Its leadership includes Srivani Junoothula (Managing Director), Kishore Babu Bathula (Director). Past directors included Srivani Junoothula, Swaroopa Rani Kandagatla, Kishore Babu Bathula. It holds ₹1.72 M open charges and ₹4.22 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2Nd Floor, Plot No 151, Sy No 125, Mallapur Main Road, Hdfc Atm, Nacharam, Medchal, Malkajgiri, Uppal, Telangana, 500076.
U24110TG1999PTC031995
031995
30 June 1999
₹4.80 M
₹4.61 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Suzikem Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srivani Junoothula | Managing Director | 16 Dec 2020 | Current |
| Kishore Babu Bathula | Director | 01 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 16 Dec 2020 | Past |
| Pramod Abcsdd | Director | 17 Nov 2022 | Past |
| Pramod Abcsdd | Additional Director | 01 Aug 2021 | Past |
| Pramod Abcsdd | Director | 17 Nov 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Suzikem Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 53.99% decrease. The company also saw a substantial fall in profitability, with a 57.83% decrease in profit. The company's net worth moved up by a moderate rise of 2.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Suzikem Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,717,000.00
₹42,193,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2021 | Hdfc Bank Limited | ₹1.72 M | Open |
| 29 Apr 2016 | Others | ₹1.41 Cr | Satisfied |
| 05 May 2012 | Allahabad Bank | ₹5.86 M | Satisfied |
| 22 Aug 2008 | Andhra Pradesh State Financial Corporation | ₹2.00 M | Satisfied |
| 29 Oct 2001 | Allahabad Bank | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Suzikem Drugs has a workforce of 9 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Suzikem Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suzikem Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Suzikem Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Suzikem Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity Kishore Babu Bathula was appointed as a Director was appointed as a Director on 01 Aug 2021 & has been associated with this company since 4 years 4 months . was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 1.72 M with Charge ID 100443698 was registered on 28 Jan 2021. was completed.
Srivani Junoothula was appointed as a Managing Director was appointed as a Managing Director on 16 Dec 2020 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
A charge registered on 29 Apr 2016 via Charge ID 100050946 with Others was fully satisfied on 26 Oct 2020. was recorded as a recent event.
The CIN of Suzikem Drugs Private Limited is U24110TG1999PTC031995.
Suzikem Drugs Private Limited is headquartered at 2Nd Floor, Plot No 151, Sy No 125, Mallapur Main Road, Hdfc Atm, Nacharam, Medchal, Malkajgiri, Uppal, Telangana, 500076.
Suzikem Drugs Private Limited was incorporated on 30 June 1999.
The current directors of Suzikem Drugs Private Limited are
The primary industry of Suzikem Drugs Private Limited is Manufacturing.
Suzikem Drugs Private Limited is unlisted.
The authorized capital of Suzikem Drugs Private Limited is ₹4.80 M, and the paid-up capital is ₹4.61 M.
The compliance status of Suzikem Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX